In a recent development, lawmakers in the United States have expressed concerns over China's WuXi AppTec biotech firm and are calling for sanctions to be imposed on the company. This call for action is a result of growing tensions between the two nations amidst heightened scrutiny of China's biotech industry.
WuXi AppTec is one of China's leading contract research organizations, specializing in providing services to the global pharmaceutical and biotech industries. Operating in more than 30 countries, the firm offers a range of services, including research and development, laboratory testing, and manufacturing.